Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 28, 2015 11:28 AM ET

Life Sciences Tools and Services

Company Overview of mBio Diagnostics, Inc.

Company Overview

mBio Diagnostics, Inc., a clinical diagnostics and life sciences technology company, develops a suite of multiplexed diagnostic tests. Its products include CD4 System, which provides CD4 T helper cell counts at the point-of care; and MBio Array, a multiplexed fluorescence immunoassay system that provides the simultaneous measurement of multiple analytes from a sample. The company offers its products based on LightDeck, a fluorescence assay illumination method and variation on planar waveguide technology used for performing sensitive biological assays. It offers its products for HIV/AIDS, acute HIV infection, rapid CD4 cell counting, and hepatitis and syphilis co-infection testing application...

3180 Sterling Circle

Suite 100

Boulder, CO 80301

United States

Founded in 2009





Key Executives for mBio Diagnostics, Inc.

Founder and Chief Executive Officer
President and Counsel
Vice President
Vice President of Regulatory Affairs and Quality Assurance
Compensation as of Fiscal Year 2014.

mBio Diagnostics, Inc. Key Developments

MBio Diagnostics, Inc. Wins Contract for Diagnostic Development With the U.S. Army

MBio Diagnostics, Inc. announced it was awarded a three-year development contract with the U.S. Army's Walter Reed Army Institute of Research (WRAIR) for the Development of a Ruggedized Portable Cartridge Reader for Malaria Diagnosis.Under this contract, MBio Diagnostics will develop a low cost, multi-analyte point-of-care (POC) diagnostic device for malaria with enhanced sensitivity, quantitation capabilities, and automated data capture and transmission, using the company's planar waveguide LightDeck(R) technology. The work will be carried out collaboratively with Dr. John Waitumbi of the United States Army Medical Research Unit-Kenya (USAMRU-K), which is a Special Foreign Activity of the WRAIR headquartered in Nairobi, Kenya. The USAMRU-K unit develops and tests improved means for predicting, detecting, preventing, and treating infectious disease threats important to the U.S. Military as well as conducts surveillance, training, research and response activities related to emerging infectious diseases threats.

MBio Diagnostics, Inc. Announces Creation of Scientific Advisory Board

MBio Diagnostics, Inc. announced the formation of a Scientific Advisory Board (SAB) composed of medical professionals with deep expertise in global health issues. The SAB will help advance MBio Diagnostics' mission to increase access to quality healthcare by delivering innovative and low cost point-of-care (POC) diagnostics. Board members will assist the management team with assessing technology options, developing new POC diagnostics in limited-resource settings, and will provide expertise on future clinical diagnostics trends. Robert Schooley, M.D. is the Division Head and Professor of Medicine in the Department of Medicine, Division of Infectious Disease, at the University of California, San Diego (UCSD). Dr. Benson, M.D. is a Professor of Medicine, Senior Attending Physician, and the Infectious Disease Fellowship Training Program Director in the Department of Medicine/Division of Infectious Disease at the University of California, San Diego School of Medicine. She is the principal investigator and Chair of the Executive Committee and Vice Chair of the Scientific Steering Committee of the NIH/NIAID AIDS Clinical Trials Group (ACTG), and is a past chair of the NIH Office of AIDS Research Advisory Council. Bruce Walker, M.D. is the Director of the Ragon Institute of MGH, MIT, and Harvard, a Professor of Medicine at Harvard Medical School, and a Howard Hughes Medical Institute Investigator.

MBio Diagnostics, Inc. Appoints Robert J. Silverman as Board of Directors

MBio Diagnostics, Inc. announced that it has appointed Robert J. Silverman to the company board of directors. Mr. Silverman served as the CEO of mtm Laboratories AG. He was instrumental in raising capital and building mtm into a global, fully integrated commercial business.

Similar Private Companies By Industry

Company Name Region
Rainforest Nutritionals, Inc. United States
Genome Designs, Inc. United States
Bio-Newco, Inc. United States
Johnston, Zabor, McManus, Inc. United States
BioNex Solutions Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact mBio Diagnostics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at